» Articles » PMID: 20842449

Down-regulation of Achaete-scute Complex Homolog 1 (ASCL1) in Neuroblastoma Cells Induces Up-regulation of Insulin-like Growth Factor 2 (IGF2)

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2010 Sep 16
PMID 20842449
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma (NB) is the most common extra-cranial solid pediatric tumor. The prognosis of patients with NB has been improved during the last decades. However, treatment results for patients with advanced tumor stages are still unsatisfying. NB cells are characterized by a high tendency for spontaneous or induced differentiation. During differentiation, down-regulation of the basic helix-loop-helix transcription factor achaete-scute complex homolog 1 (ASCL1) has been observed but the consequences of ASCL1 down-regulation have not been elucidated. We used RNA interference to knock-down ASCL1 in NB cells. DNA microarray analysis was used for the identification of ASCL1-regulated genes. Furthermore, conventional and quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used for validation of ASCL1-regulated genes. Down-regulation of ASCL1 influenced the expression of several genes. After down-regulation of ASCL1, we observed very high expression of insulin-like growth factor 2 (IGF2), a factor that is known to be induced during differentiation of NB cells. RT-PCR indicated up-regulation of multiple IGF2 transcript variants after ASCL1 knock-down. Our data suggest that the ASCL1-pathway is responsible for the up-regulation of IGF2 during NB differentiation.

Citing Articles

Activation of Proneuronal Transcription Factor Ascl1 in Maternal Liver Ensures a Healthy Pregnancy.

Lee J, Garcia V, Nambiar S, Jiang H, Dai G Cell Mol Gastroenterol Hepatol. 2021; 13(1):35-55.

PMID: 34438112 PMC: 8600092. DOI: 10.1016/j.jcmgh.2021.08.009.


ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.

Wang L, Tan T, Durbin A, Zimmerman M, Abraham B, Tan S Nat Commun. 2019; 10(1):5622.

PMID: 31819055 PMC: 6901540. DOI: 10.1038/s41467-019-13515-5.


Type I insulin-like growth factor receptor signaling in hematological malignancies.

Vishwamitra D, George S, Shi P, Kaseb A, Amin H Oncotarget. 2016; 8(1):1814-1844.

PMID: 27661006 PMC: 5352101. DOI: 10.18632/oncotarget.12123.


Sequence and expression of the chicken membrane-associated phospholipases A1 alpha (LIPH) and beta (LIPI).

Hesse M, Willscher E, Schmiedel B, Posch S, Golbik R, Staege M Mol Biol Rep. 2011; 39(1):761-9.

PMID: 21559832 DOI: 10.1007/s11033-011-0796-0.


Expression of multiple membrane-associated phospholipase A1 beta transcript variants and lysophosphatidic acid receptors in Ewing tumor cells.

Schmiedel B, Hutter C, Hesse M, Staege M Mol Biol Rep. 2010; 38(7):4619-28.

PMID: 21132378 DOI: 10.1007/s11033-010-0595-z.

References
1.
Banet G, Bibi O, Matouk I, Ayesh S, Laster M, Kimber K . Characterization of human and mouse H19 regulatory sequences. Mol Biol Rep. 2001; 27(3):157-65. DOI: 10.1023/a:1007139713781. View

2.
Reynolds C, Matthay K, Villablanca J, Maurer B . Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 2003; 197(1-2):185-92. DOI: 10.1016/s0304-3835(03)00108-3. View

3.
Liangliang X, Yonghui H, Shunmei E, Shoufang G, Wei Z, Jiangying Z . Dominant-positive HSF1 decreases alpha-synuclein level and alpha-synuclein-induced toxicity. Mol Biol Rep. 2009; 37(4):1875-81. DOI: 10.1007/s11033-009-9623-2. View

4.
Liu W, Laux H, Henry J, Bolton T, Dalgleish A, Galustian C . A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro. Mol Biol Rep. 2009; 37(4):1801-14. DOI: 10.1007/s11033-009-9614-3. View

5.
Vu T, Li T, Nguyen D, Nguyen B, Yao X, Hu J . Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Genomics. 2000; 64(2):132-43. DOI: 10.1006/geno.1999.6094. View